A carregar...
Autoantibodies Against Methylglyoxal-Modified Apolipoprotein B100 and ApoB100 Peptide Are Associated With Less Coronary Artery Atherosclerosis and Retinopathy in Long-Term Type 1 Diabetes
OBJECTIVE: Methylglyoxal (MGO), a reactive aldehyde forming advanced glycation end products (AGEs), is increased in diabetes and recognized by the immune system, resulting in anti-AGE–specific autoantibodies. The association of these immune responses with macro- and microvascular complications in ty...
Na minha lista:
| Publicado no: | Diabetes Care |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Diabetes Association
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8247486/ https://ncbi.nlm.nih.gov/pubmed/33858856 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc20-2089 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|